Sinus aspergillosis is a fungal infection that affects the sinuses. People with weakened immune systems and respiratory conditions are more likely to develop this condition. Aspergillus is a mold that ...

Approval covers adults and children ≥6 years with prior sinonasal surgery, representing the first FDA-cleared pharmacologic option specifically for AFRS and dupilumab’s ninth U.S. indication.

Breakthroughs, discoveries, and DIY tips sent six days a week. Terms of Service and Privacy Policy. Allergies are on the rise, however, there’s still a great deal ...

One commercial frequently aired during Sports Radio's coverage of the NCAA Basketball Tourney this weekend presented a frightening image. The commercial starts innocently enough with a conversation ...

Treatment with dupilumab led to significant reductions in sinus opacification, nasal congestion and nasal polyps in patients with allergic fungal rhinosinusitis. Dupilumab, an interleukin-4 receptor ...